Research Associate ll- In Vivo Pharmacology

We are the leading oncology CRO, developing novel treatments for patients that need them most. Our team is fully dedicated to oncology – it is all we do – combining innovation and expertise to quickly move medicines from preclinical development into clinical trials. Adaptive and forward-thinking – we guide our client's therapy through the most critical development milestones from the lab to planning their regulatory and clinical strategy. Our ultimate goal? To help patients.

Position Summary:

The Research Associate II – In Vivo Pharmacology is involved in many aspects of the nonclinical department’s operations; chiefly the execution of in vivo pharmacology studies. Other responsibilities include performance of general laboratory duties and in vitro techniques.

Essential Functions:

• Executes in vivo pharmacology studies in rodents.
• Maintains detailed laboratory files and documents.
• Proactively prepares for assigned study protocols, as appropriate.
• Adheres to study protocols.
• Collects and assesses data.
• Participates in weekly lab meetings by updating the department of progress, results, and future studies.
• Maintains lab equipment.
• Performs general laboratory duties.
• Performs necropsies.
• Performs other laboratory duties as assigned.
• Assists other labs as needed.
• Works closely with lab leadership and project managers to properly prepare for and execute assigned pharmacology studies
• Performs other duties as assigned.

Job Requirements:

• Bachelor’s degree in a science-related field with 2 years’ direct animal research; or 5 years’ direct animal research experience with no degree required.

Required Specialized/Technical Skills:

• Experience in rodent handling and procedures, especially in cancer pharmacology.
• Experience in tissue culture techniques and other in vitro assays.
• Experience in general laboratory techniques.
• Strong attention to detail.
• Overtime work required.
• Highly organized.

Born from the Translational Genomics Research Institute (TGen), TD2 was formed in 2003 as a subsidiary of TGen, and less than two years later, opened its doors on the campus of the Mayo Clinic in Scottsdale, Ariz. In our 17 years of business, we have helped more than 600 biotech and pharma companies, maintaining hundreds of client studies per year. Among them, our team has been involved in more than 600 first-in-man major oncology medicines, including numerous trials that have led to approvals in both rare and large indications.

TD2 is an equal opportunity employer and does not discriminate on the basis of race, color, national origin, creed, disability, veteran’s status, gender, sexual orientation, gender identity, or gender expression.